Predicted to enable hydrolase activity. Predicted to be involved in microfibril assembly. Predicted to act upstream of or within elastic fiber assembly. Predicted to be located in microfibril. Human ortholog(s) of this gene implicated in asthma and thoracic aortic aneurysm. Orthologous to human THSD4 (thrombospondin type 1 domain containing 4); INTERACTS WITH atrazine; bisphenol A; methoxychlor.
AABR07070307.1; LOC315728; RGD1566296; similar to RIKEN cDNA B230114P05; thrombospondin type-1 domain-containing protein 4; thrombospondin, type I, domain containing 4
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ...
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ...
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ...
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THSD4 mRNA; [Coumestrol co-treated with resveratrol] more ...
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ...